Net Loss per Share (Tables)

9 Months Ended

Sep. 30, 2026

Earnings Per Share [Abstract]

Schedule of basic and diluted earnings per share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):


		Three Months Ended September 30, 2026												Nine Months Ended September 30, 2026
		Loss Allocation				Weighted Average Shares Outstanding				Loss Per Share - Basic and Diluted				Loss Allocation				Weighted Average Shares Outstanding				Loss Per Share - Basic and Diluted
Common Stock and pre-funded warrants		$	(43,152	)			13,525,610			$	(3.19	)		$	(72,623	)			5,412,840			$	(13.42	)
Series B Preferred Stock			(3,273	)			1,026			$	(3,190.41	)			(4,672	)			348			$	(13,416.90	)
Net loss		$	(46,425	)										$	(77,295	)

		Three Months Ended September 30, 2025												Nine Months Ended September 30, 2025
Common Stock		$	(21,723	)			550,061			$	(39.49	)		$	(21,948	)			460,382			$	(47.67	)
Net loss		$	(21,723	)										$	(21,948	)

(1) The weighted-average number of shares of as-converted Series B Preferred Shares used in the loss allocation was 1,025,849 and 348,190 for the three and nine months ended September 30, 2026, respectively.

Schedule of Anti-Dilutive Effect Excluded from Potential Computation of Diluted Net Loss Per Share

The Company excluded potential common shares from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an anti-dilutive effect:


		September 30, 2026				September 30, 2025
Outstanding unvested restricted stock awards			142,587				—
Outstanding and issued warrant to Parasa			228,671				—
Outstanding and issued common stock options			7,277,108				—
			7,648,366				—